University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...

SGLT2 inhibitor use was associated with a significantly lower risk for androgen deprivation therapy (ADT) failure and next-generation hormonal agent failure in men with prostate cancer. SGLT2 ...

NHS England has announced that men whose high-risk prostate cancer has not yet spread will be able to receive the drug, ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Advanced prostate cancer cases are rising worldwide as fewer men undergo routine PSA screening and early symptoms go ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...

Localized prostate cancer treatments include radical prostatectomy and focal therapy, with the latter targeting only cancerous areas to preserve healthy tissue. Focal therapy allows for active ...

England will join Scotland and Wales in widening access to the prostate cancer drug abiraterone, following a public campaign.

Prostate Cancer UK said a 42 per cent rise in diagnoses in the past decade is thanks to increased awareness of the disease by ...